Cooperative Agreement W81XWH2220008

The Department of the Army Medical Command awarded a $2,430,944 project grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Texas Health Science Center of San Antonio. The grant aims to develop a web-based training for cognitive behavioral therapy for nightmares (CBT-N) to be delivered from September 1, 2021 through August 31, 2025. Several sub-awards were provided to partner organizations to support content development, video production,...

The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Lumostech, Inc. under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a smart sleep mask and mobile application to improve sleep for adolescents. The one-year project will apply light flash technology delivered through a sleep mask to advance teenagers' circadian phases without disrupting daytime activities. Cognitive behavioral therapy delivered via mobile...

This $2,301,698 project grant awarded on September 30, 2023 by the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports the "Virtual Insomnia Patients (VIPS) to Accelerate Dissemination of Precision Diagnosis and Treatment of Insomnia" research project. The prime awardee, Arizona State University, will collaborate with sub-awardees including the University of Texas Health Science Center at San Antonio, University of North Texas, and the...

This National Science Foundation Project Grant of $255,851 awarded on September 15, 2022 will support the development of a neuromodulation device to promote healthy sleep cycles through the completion of prototype engineering. The awardee, Neurolight Inc. of Suffern, New York, will utilize controlled light and sound stimuli delivered via an externally worn system to transpose normal brain wave patterns associated with desired sleep states into recipients suffering from sleep disorders. This aims...

This federal Project Grant award of $2,398,281.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program aims to increase access to evidence-based PTSD treatment for military service members and veterans through Behavioral Health Technician-delivered Written Exposure Therapy (WET). The primary awardee, Palo Alto Veterans Institute for Research (Pavir), will oversee the overall project objectives, which include providing WET training to...

The federal Project Grant award of $885,349.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, with a period of performance from June 1, 2025 to May 31, 2028, supports the development of a blood test to measure sleep deprivation and circadian time. The primary awardee is Brigham & Women's Hospital Inc., which is a prominent academic medical center and research institution affiliated with Harvard Medical School...

This $3,823,679 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and evaluation of a web-based training program for brief cognitive behavioral therapy (BCBT) for suicide prevention. The prime awardee, The Ohio State University, is collaborating with subrecipients The University of Texas Health Science Center at San Antonio, the Medical University of South Carolina, and the University of Memphis...

The Department of the Army Medical Command awarded a $384,001 Project Grant to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2022 to February 29, 2024 to investigate the neural circuit mechanisms of stress-induced insomnia and metabolic dysfunction. Through its support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...

This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,498,158 to Synaptic Health LLC to develop a novel closed-loop feedback neuromodulation system to improve slow wave sleep in Alzheimer's disease patients. The goal of this Phase I project is to create a testable prototype that can sense sleep architecture and provide peripheral neuromodulation stimulation to individuals over 65, a high-risk group for Alzheimer's disease. Successful...

This Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports a randomized controlled trial to evaluate a couple-oriented behavioral therapy intervention to improve continuous positive airway pressure (CPAP) adherence among African American patients with obstructive sleep apnea (OSA) and their bed partners. The $1,474,280 award will fund a study involving 220 African American patients and their partners across 2 urban...